Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1525 of 1631 entries
View as:

Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)

Phase: N/A Priority: Normal
NCT ID: NCT03210246 Org: User:
Start: 07/17/17 End: 01/23/19 Due: 01/23/20

Risk of Acute Liver Injury in Users of Antimicrobials

Phase: N/A Priority: Normal
NCT ID: NCT01434173 Org: User:
Start: 07/31/01 End: 03/31/09 Due: 03/31/10

Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00657644 Org: User:
Start: 08/31/03 End: 03/31/04 Due: 03/31/05

Long-term Study in Chronic Kidney Disease (Extension From Study 14817)

Phase: N/A Priority: Normal
NCT ID: NCT01187628 Org: User:
Start: 09/30/10 End: 04/30/13 Due: 04/30/14

BAY38-9456, 5/10/20mg, vs.Placebo in Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00665054 Org: User:
Start: 08/31/04 End: 08/31/05 Due: 08/31/06

A Study to Learn How the Study Treatment BAY2395840 Moves Into, Through and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Moderate Reduced Kidney Function and in Healthy Male and Female Participants With Normal Kidney Function

Phase: N/A Priority: Normal
NCT ID: NCT05406219 Org: User:
Start: 05/15/23 End: 10/12/23 Due: 10/12/24

Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on Betaferon

Phase: N/A Priority: Normal
NCT ID: NCT01766063 Org: User:
Start: 12/06/12 End: 03/14/17 Due: 03/14/18

Evaluation of Patient and Physician Reported Reasons for Switching Factor VIII Replacement Therapies

Phase: N/A Priority: Normal
NCT ID: NCT03405337 Org: User:
Start: 02/14/18 End: 06/13/18 Due: 06/13/19

Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.

Phase: N/A Priority: Normal
NCT ID: NCT00764387 Org: User:
Start: 03/31/08 End: 05/31/09 Due: 05/31/10

SH T00186 in the Treatment of Primary Dysmenorrhea

Phase: N/A Priority: Normal
NCT ID: NCT00569244 Org: User:
Start: 12/31/07 End: 12/31/09 Due: 12/31/10

BAY 77-1931 Long-term Extension From Phase II Study

Phase: N/A Priority: Normal
NCT ID: NCT00769496 Org: User:
Start: 01/31/05 End: 05/31/08 Due: 05/31/09

To Test for Photo Allergy Reaction of Sunscreens

Phase: N/A Priority: Normal
NCT ID: NCT02872220 Org: User:
Start: 03/23/15 End: 05/08/15 Due: 05/08/16

A Study Using the LMC Diabetes Registry to Learn More About Chronic Kidney Disease (CKD) in Canadian Patients With Type 2 Diabetes (T2D)

Phase: N/A Priority: Normal
NCT ID: NCT04445181 Org: User:
Start: 07/01/20 End: 11/23/20 Due: 11/23/21

A Study of Molidustat for Correction of Renal Anemia in Dialysis Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03351166 Org: User:
Start: 01/22/18 End: 11/20/18 Due: 11/20/19

Betaferon/ Betaseron (Interferon Beta-1b) in Patients With Chronic Viral Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT00185250 Org: User:
Start: 12/31/02 End: 11/30/05 Due: 11/30/06

Study on the Safety of BAY1817080, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug in Participants With Impaired Liver Function or Normal Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT04454424 Org: User:
Start: 07/23/20 End: 12/15/21 Due: 12/15/22

Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation

Phase: N/A Priority: Normal
NCT ID: NCT01894035 Org: User:
Start: 09/23/13 End: 04/13/17 Due: 04/13/18

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)

Phase: N/A Priority: Normal
NCT ID: NCT03400943 Org: User:
Start: 01/17/18 End: 04/06/22 Due: 04/06/23

A Study to Learn How Much Rosuvastatin Gets Into the Blood When Taken With or Without Elinzanetant and to Learn About the Safety of Elinzanetant in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04889287 Org: User:
Start: 05/26/21 End: 09/29/21 Due: 09/29/22

Study to Observe Safety and Efficacy of Nexavar in Treatment of Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01353794 Org: User:
Start: 12/31/14 End: 04/30/18 Due: 04/30/19

Study to Investigate Efficacy and Safety of a New Oral Contraceptive

Phase: N/A Priority: Normal
NCT ID: NCT00185289 Org: User:
Start: 04/30/04 End: 07/31/06 Due: 07/31/07

Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.

Phase: N/A Priority: Normal
NCT ID: NCT01031459 Org: User:
Start: 01/31/10 End: 12/31/10 Due: 12/31/11

Low-dose Hormone Therapy for Relief of Vasomotor Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00446199 Org: User:
Start: 03/31/07 End: 11/30/08 Due: 11/30/09

18348-Human Phototoxicity Test

Phase: N/A Priority: Normal
NCT ID: NCT02823483 Org: User:
Start: 11/30/15 End: 11/30/15 Due: 11/30/16

Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00976209 Org: User:
Start: 08/31/09 End: 11/30/09 Due: 11/30/10